Want to join the conversation?
Biotechnology company $TMO and $AFFX, provider of cellular and genetic analysis products, said that their Boards of Directors have unanimously approved Thermo Fisher's acquisition of Affymetrix for $14 per share in cash. The transaction represents a purchase price of about $1.3Bil.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?